Skip to main content
SpringerLink
Log in

The Impact of Skin and Hair Disease in Ethnic Skin

  • Chapter
  • First Online:
Dermatoanthropology of Ethnic Skin and Hair

Abstract

The ethnic/racial demographic of the United States is in the midst of significant change and physicians must be adept at recognizing and effectively treating dermatologic disease states in patients with skin of color. Inherent in effectively treating these cutaneous diseases is sufficiently understanding the patient’s viewpoint about his/her disease, as well as hindrances to treatment, compliance, patient satisfaction, and access to leading treatment modalities. In this chapter, we utilize quality of life studies in vitiligo, melasma, acne, keloids, alopecia and sarcoidosis, in order to increase understanding of the extent of disease burden in these disease states and provide improved care.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Finlay AY, Kelly SE. Psoriasis—an index of disability. Clin Exp Dermatol. 1987;12(1):8–11.

    Article  CAS  PubMed  Google Scholar 

  2. Finlay AY. Quality of life assessments in dermatology. Sem Cutaneous Med Surg. 1998;17(4):291–6.

    Article  CAS  Google Scholar 

  3. Balkrishnan R, McMichael AJ, Camacho FT, Saltzberg F, Housman TS, Grummer S, et al. Development and validation of a health-related quality of life instrument for women with melasma. Br J Dermatol. 2003;149(3):572–7.

    Article  CAS  PubMed  Google Scholar 

  4. Dominguez AR, Balkrishnan R, Ellzey AR, Pandya AG. Melasma in Latina patients: cross-cultural adaptation and validation of a quality-of-life questionnaire in Spanish language. J Am Acad Dermatol. 2006;55(1):59–66.

    Article  PubMed  Google Scholar 

  5. McHorney CA, Ware JE Jr, Raczek AE. The MOS 36-Item Short-Form Health Survey (SF-36): II. Psychometric and clinical tests of validity in measuring physical and mental health constructs. Med Care. 1993;31(3):247–63.

    Article  CAS  PubMed  Google Scholar 

  6. Chren MM, Lasek RJ, Quinn LM, Mostow EN, Zyzanski SJ. Skindex, a quality-of-life measure for patients with skin disease: reliability, validity, and responsiveness. J Invest Dermatol 1996;107(5):707–13.

    Google Scholar 

  7. Finlay AY, Khan GK. Dermatology Life Quality Index (DLQI)—a simple practical measure for routine clinical use. Clin Exp Dermatol. 1994;19(3):210–6.

    Article  CAS  PubMed  Google Scholar 

  8. Motley RJ, Finlay AY. Practical use of a disability index in the routine management of acne. Clin Exp Dermatol. 1992;17(1):1–3.

    Article  CAS  PubMed  Google Scholar 

  9. Whalley D, Mckenna SP, Dewar AL, Erdman RA, Kohlmann T, Niero M, et al. A new instrument for assessing quality of life in atopic dermatitis: international development of the Quality of Life Index for Atopic Dermatitis (QoLIAD). Br J Dermatol. 2004;150(2):274–83.

    Article  CAS  PubMed  Google Scholar 

  10. Baiardini I, Pasquali M, Braido F, Fumagalli F, Guerra L, Compalati E, et al. A new tool to evaluate the impact of chronic urticaria on quality of life: chronic urticaria quality of life questionnaire (CU-Q2oL). Allergy Eur J Allergy Clin Immunol. 2005;60(8):1073–8.

    Article  CAS  Google Scholar 

  11. Linthorst Homan MW, Spuls PI, de Korte J, Bos JD, Sprangers MA, van der Veen JPW. The burden of vitiligo: patient characteristics associated with quality of life. J Am Acad Dermatol. 2009 9;61(3):411–20.

    Google Scholar 

  12. Chren MM, Lasek RJ, Flocke SA, Zyzanski SJ. Improved discriminative and evaluative capability of a refined version of Skindex, a quality-of-life instrument for patients with skin diseases. Arch Dermatol 1997;133(11):1433–40.

    Google Scholar 

  13. Rogers A, DeLong LK, Chen SC. Clinical meaning in skin-specific quality of life instruments: a comparison of the dermatology life quality index and skindex banding systems. Dermatol Clin. 2012 4;30(2):333–42.

    Google Scholar 

  14. Halder RM, Grimes PE, McLaurin CI, Kress MA, Kenney JA Jr. Incidence of common dermatoses in a predominantly black dermatologic practice. Cutis. 1983;32(4):388–90.

    CAS  PubMed  Google Scholar 

  15. Ongenae K, Van Geel N, De Schepper S, Haeghen YV, Naeyaert J-M. Management of vitiligo patients and attitude of dermatologists towards vitiligo. Eur J Dermatol. 2004;14(3):177–81.

    Google Scholar 

  16. Njoo MD, Bossuyt PMM, Westerhof W. Management of vitiligo. Results of a questionnaire among dermatologists in the Netherlands. Int J Dermatol. 1999;38(11):866–72.

    Article  CAS  PubMed  Google Scholar 

  17. Ongenae K, Beelaert L, van Geel N, Naeyaert J-M. Psychosocial effects of vitiligo. J Eur Acad Dermatol Venereol. 2006;20(1):1–8.

    Google Scholar 

  18. Grimes PE. White patches and bruised souls: advances in the pathogenesis and treatment of vitiligo. J Am Acad Dermatol. 2004 7;51(1, Supplement):5–7.

    Google Scholar 

  19. Chaturvedi SK, Singh G, Gupta N. Stigma experience in skin disorders: an Indian perspective. Dermatol Clin. 2005;23(4 SPEC. ISS.):635–42.

    Google Scholar 

  20. Parsad D, Dogra SF, Kanwar AJ. Quality of life in patients with vitiligo. Health and quality of life outcomes JID - 101153626 0630.

    Google Scholar 

  21. Kaur H, Ramesh V. Social problems of women leprosy patients—a study conducted at 2 urban leprosy centres in Delhi. Lepr Rev. 1994;65(4):361–75.

    CAS  PubMed  Google Scholar 

  22. Rao S, Garole V, Walawalkar S, Khot S, Karandikar N. Gender differentials in the social impact of leprosy. Lepr Rev. 1996;67(3):190–9.

    CAS  PubMed  Google Scholar 

  23. Amer AAA, Gao X. Quality of life in patients with vitiligo: an analysis of the dermatology life quality index outcome over the past two decades. Int J Dermatol. 2016:n/a-n/a.

    Google Scholar 

  24. Lundberg L, Johannesson M, Silverdahl M, Hermansson C, Lindberg M. Health-related quality of life in patients with psoriasis and atopic dermatitis measured with SF-36, DLQI and a subjective measure of disease activity. Acta Derm-Venereol. 2000;80(6):430–4.

    Article  CAS  PubMed  Google Scholar 

  25. Holm EA, Wulf HC, Stegmann H, Jemec GBE. Life quality assessment among patients with atopic eczema. Br J Dermatol. 2006;154(4):719–25.

    Article  CAS  PubMed  Google Scholar 

  26. Wahl A, Hanestad BR, Wiklund I, Moum T. Coping and quality of life in patients with psoriasis. Qual Life Res. 1999;8(5):427–33.

    Article  CAS  PubMed  Google Scholar 

  27. Wahl A, Moum T, Hanestad BR, Wiklund I. The relationship between demographic and clinical variables, and quality of life aspects in patients with psoriasis. Qual Life Res. 1999;8(4):319–26.

    Article  CAS  PubMed  Google Scholar 

  28. Wallenhammar L-M, Nyfjäll M, Lindberg M, Meding B. Health-related quality of life and hand eczema—a comparison of two instruments, including factor analysis. J Invest Dermatol. 2004;122(6):1381–9.

    Google Scholar 

  29. Ezzedine K, Grimes PE, Meurant J-, Seneschal J, Léauté-Labrèze C, Ballanger F, et al. Living with vitiligo: results from a national survey indicate differences between skin phototypes. Br J Dermatol. 2015;173(2):607–9.

    Article  CAS  PubMed  Google Scholar 

  30. Teulings HE, Overkamp M, Ceylan E, Nieuweboer-Krobotova L, Bos JD, Nijsten T, et al. Decreased risk of melanoma and nonmelanoma skin cancer in patients with vitiligo: a survey among 1307 patients and their partners. Br J Dermatol. 2013;168(1):162–71.

    Article  CAS  PubMed  Google Scholar 

  31. Paradisi A, Tabolli S, Didona B, Sobrino L, Russo N, Abeni D. Markedly reduced incidence of melanoma and nonmelanoma skin cancer in a nonconcurrent cohort of 10,040 patients with vitiligo. J Am Acad Dermatol. 2014 12;71(6):1110–6.

    Google Scholar 

  32. Sheth VM, Pandya AG. Melasma: a comprehensive update: Part i. J Am Acad Dermatol. 2011;65(4):689–97.

    Article  PubMed  Google Scholar 

  33. Sarkar R, Puri P, Jain Jr RK, Singh AF, Desai A. Melasma in men: a clinical, aetiological and histological study. J Eur Acad Dermatol Venereol: JEADV JID - 9216037 1108.

    Google Scholar 

  34. Harumi O, Goh CL. The effect of melasma on the quality of life in a sample of women living in Singapore. J Clin Aesthetic Dermatol. 2016;9(1):21–4.

    Google Scholar 

  35. Freitag FM, Cestari TF, Leopoldo LR, Paludo P, Boza JC. Effect of melasma on quality of life in a sample of women living in southern Brazil. J Eur Acad Dermatol Venereol: JEADV JID - 9216037 0811.

    Google Scholar 

  36. Ikino JK, Nunes DH, Silva VP, Frode TS, Sens MM. Melasma and assessment of the quality of life in Brazilian women. An Bras Dermatol. 2015;90(2):196–200.

    Google Scholar 

  37. Stern RS. Medication and medical service utilization for acne 1995–1998. J Am Acad Dermatol. JID - 7907132 0125.

    Google Scholar 

  38. Shah SK, Bhanusali DG, Sachdev A, Geria AN, Alexis AF. A survey of skin conditions and concerns in South Asian Americans: a community-based study. J Drugs Dermatol. 2011;10(5):524–8.

    PubMed  Google Scholar 

  39. Alexis AF, Sergay AB, Taylor SC. Common dermatologic disorders in skin of color: a comparative practice survey. Cutis. 2007;80(5):387–94.

    PubMed  Google Scholar 

  40. Poli F. Acne on pigmented skin. Int J Dermatol. 2007;46(Suppl 1):39–41.

    Article  PubMed  Google Scholar 

  41. Child FJ, Fuller LC, Higgins EM, Du Vivier AW. A study of the spectrum of skin disease occurring in a black population in south-east London. Br J Dermatol. 1999;141(3):512–7.

    Article  CAS  PubMed  Google Scholar 

  42. Perkins AC, Cheng CE, Hillebrand GG, Miyamoto K, Kimball AB. Comparison of the epidemiology of acne vulgaris among Caucasian, Asian, Continental Indian and African American women. J Eur Acad Dermatol Venereol. 2011;25(9):1054–60.

    Article  CAS  PubMed  Google Scholar 

  43. Callender VD, Alexis AF, Daniels SR, Kawata AK, Burk CT, Wilcox TK, et al. Racial differences in clinical characteristics, perceptions and behaviors, and psychosocial impact of adult female acne. J Clin Aesthet Dermatol. 2014;7(7):19–31.

    PubMed  PubMed Central  Google Scholar 

  44. Alexis AF. Acne in patients with skin of color. J Drugs Dermatol. 2011;10(6):s13–6.

    PubMed  Google Scholar 

  45. Lasek RJ, Chren MM. Acne vulgaris and the quality of life of adult dermatology patients. Arch Dermatol. 1998;134(4):454–8.

    Article  CAS  PubMed  Google Scholar 

  46. Mallon E, Newton JN, Klassen A, Stewart-Brown SL, Ryan TJ, Finlay AY. The quality of life in acne: a comparison with general medical conditions using generic questionnaires. Br J Dermatol. 1999;140(4):672–6.

    Article  CAS  PubMed  Google Scholar 

  47. Chike-Obi CJ, Cole PD, Brissett AE. Keloids: pathogenesis, clinical features, and management. Semin Plast Surg. 2009;23(3):178–84.

    Article  PubMed  PubMed Central  Google Scholar 

  48. Kouwenberg CA, Bijlard E, Timman R, Hovius SE, Busschbach JJ, Mureau MA. Emotional quality of life is severely affected by keloid disease: pain and itch are the main determinants of burden. Plast Reconstr Surg. 2015;136(4 Suppl):150–1.

    Article  PubMed  Google Scholar 

  49. Aaronson NK, Muller M, Cohen PD, Essink-Bot ML, Fekkes M, Sanderman R, et al. Translation, validation, and norming of the Dutch language version of the SF-36 Health Survey in community and chronic disease populations. J Clin Epidemiol. 1998;51(11):1055–68.

    Article  CAS  PubMed  Google Scholar 

  50. Reinholz M, Poetschke J, Schwaiger H, Epple A, Ruzicka T, Gauglitz GG. The dermatology life quality index as a means to assess life quality in patients with different scar types. J Eur Acad Dermatol Venereol. 2015;29(11):2112–9.

    Article  CAS  PubMed  Google Scholar 

  51. van der Donk J, Passchier J, Knegt-Junk C, Van der Wegen-Keijser MH, Nieboer C, Stolz E, et al. Psychological characteristics of women with androgenetic alopecia: a controlled study. Br J Dermatol. 1991;125(3):248–52.

    Article  PubMed  Google Scholar 

  52. Van Der Donk J, Hunfeld JA, Passchier J, Knegt-Junk KJ, Nieboer C. Quality of life and maladjustment associated with hair loss in women with alopecia androgenetica. Soc Sci Med. 1994;38(1):159–63.

    Article  Google Scholar 

  53. Camacho F, García-Hernández M. Psychological features of androgenetic alopecia1. J Eur Acad Dermatol Venereol. 2002;16(5):476–80.

    Article  CAS  PubMed  Google Scholar 

  54. Dlova NC, Fabbrocini G, Lauro C, Spano M, Tosti A, Hift RH. Quality of life in South African Black women with alopecia: a pilot study. Int J Dermatol. 2015.

    Google Scholar 

  55. Chiang YZ, Bundy C, Griffiths CEM, Paus R, Harries MJ. The role of beliefs: lessons from a pilot study on illness perception, psychological distress and quality of life in patients with primary cicatricial alopecia. Br J Dermatol. 2015;172(1):130–7.

    Article  CAS  PubMed  Google Scholar 

  56. Reid EE, Haley AC, Borovicka JH, Rademaker A, West DP, Colavincenzo M, et al. Clinical severity does not reliably predict quality of life in women with alopecia areata, telogen effluvium, or androgenic alopecia. J Am Acad Dermatol. 2012 3;66(3):e97–102.

    Google Scholar 

  57. Wanat KA, Rosenbach M. Cutaneous sarcoidosis. Clin Chest Med. 2015 12;36(4):685–702.

    Google Scholar 

  58. Judson MA. Quality of life assessment in sarcoidosis. Clin Chest Med. 2015 12;36(4):739–50.

    Google Scholar 

  59. Cox CE, Donohue JF, Brown CD, Kataria YP, Judson MA. Health-related quality of life of persons with sarcoidosis. Chest. 2004;125(3):997–1004.

    Article  PubMed  Google Scholar 

  60. Cox CE, Donohue JF, Brown CD, Kataria YP, Judson MA. The Sarcoidosis Health Questionnaire: a new measure of health-related quality of life. Am J Respir Crit Care Med. 2003;168(3):323–9.

    Article  PubMed  Google Scholar 

  61. Victorson DE, Cella D, Grund H, Judson MA. A conceptual model of health-related quality of life in sarcoidosis. Qual Life Res. 2013;23(1):89–101.

    Article  PubMed  Google Scholar 

  62. Victorson DE, Choi S, Judson MA, Cella D. Development and testing of item response theory-based item banks and short forms for eye, skin and lung problems in sarcoidosis. Qual Life Res. 2013;23(4):1301–13.

    Article  PubMed  Google Scholar 

  63. Judson MA, Mack M, Beaumont JL, Watt R, Barnathan ES, Victorson DE. Validation and important differences for the Sarcoidosis Assessment Tool. A new patient-reported outcome measure. Am J Respir Crit Care Med. 2015 04/01; 2016/04;191(7):786–795.

    Google Scholar 

  64. Yeung H, Farber S, Birnbaum BK, et al. REliability and validity of cutaneous sarcoidosis outcome instruments among dermatologists, pulmonologists, and rheumatologists. JAMA Dermatol. 2015;151(12):1317–22.

    Article  PubMed  Google Scholar 

  65. Hongbo Y, Thomas CL, Harrison MA, Salek MS, Finlay AY. Translating the science of quality of life into practice: What do dermatology life quality index scores mean? J Invest Dermatol. 2005;125(4):659–64.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Dermatology, Hospital of the University of Pennsylvania, Penn Medicine, Washington Square, 16th Floor, 800 Walnut Street, Philadelphia, PA, 19107, USA

    Susan C. Taylor

  2. 3737 Market St. 11th Floor, Philadelphia, PA, 19104, USA

    Temitayo Ogunleye

Authors
  1. Temitayo Ogunleye
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Susan C. Taylor
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Susan C. Taylor .

Editor information

Editors and Affiliations

  1. Department of Dermatology, Center for Ethnic Skin, Boston University, Boston, Massachusetts, USA

    Neelam A. Vashi

  2. University of California, San Francisco, San Francisco, California, USA

    Howard I. Maibach

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer International Publishing AG

About this chapter

Cite this chapter

Ogunleye, T., Taylor, S.C. (2017). The Impact of Skin and Hair Disease in Ethnic Skin. In: Vashi, N., Maibach, H. (eds) Dermatoanthropology of Ethnic Skin and Hair. Springer, Cham. https://doi.org/10.1007/978-3-319-53961-4_2

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-53961-4_2

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-53960-7

  • Online ISBN: 978-3-319-53961-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation